ACNT vs NVS vs KO vs PEP vs PFE

For growth investors, Novartis AG (NVS) is the stronger pick with 6.

0% revenue growth year-over-year, versus -57. 9% for Ascent Industries Co. (ACNT). Pfizer Inc. (PFE) offers the better valuation at 19. 3x trailing P/E (8. 9x forward), making it the more compelling value choice. Analysts rate Ascent Industries Co. (ACNT) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Pfizer Inc.

(PFE) is the cheapest at 19. 3x versus The Coca-Cola Company at 27. 2x. On forward P/E, Pfizer Inc. is actually cheaper at 8. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Novartis AG wins at 1. 14x versus PepsiCo, Inc. 's 5. 11x — a reasonable growth-adjusted valuation.

Over the past 5 years, Novartis AG (NVS) delivered a total return of +94.

0%, compared to -13. 0% for Pfizer Inc. (PFE). Over 10 years, the gap is even starker: NVS returned +187. 2% versus PFE's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus Ascent Industries Co. 's 0. 47β — meaning ACNT is approximately -333% more volatile than KO relative to the S&P 500. On balance sheet safety, Ascent Industries Co. (ACNT) carries a lower debt/equity ratio of 15% versus 2% for PepsiCo, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Novartis AG (NVS) is pulling ahead at 6.

0% versus -57. 9% for Ascent Industries Co. (ACNT). On earnings-per-share growth, the picture is similar: Ascent Industries Co. grew EPS 56. 7% year-over-year, compared to -13. 7% for PepsiCo, Inc.. Over a 3-year CAGR, NVS leads at 8. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -7. 5% for Ascent Industries Co. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVS leads at 31. 2% versus -9. 0% for ACNT. At the gross margin level — before operating expenses — NVS leads at 75. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Novartis AG (NVS) is the more undervalued stock at a PEG of 1. 14x versus PepsiCo, Inc. 's 5. 11x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Pfizer Inc. (PFE) trades at 8. 9x forward P/E versus 25. 3x for The Coca-Cola Company — 16. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACNT: 28. 1% to $18. 00.

In this comparison, PFE (6.

6% yield), PEP (3. 9% yield), NVS (2. 6% yield), KO (2. 5% yield) pay a dividend. ACNT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, ACNT: +93. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ACNT (Basic Materials) and NVS (Healthcare) and KO (Consumer Defensive) and PEP (Consumer Defensive) and PFE (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ACNT is a small-cap quality compounder stock; NVS is a large-cap quality compounder stock; KO is a large-cap quality compounder stock; PEP is a mid-cap income-oriented stock; PFE is a mid-cap income-oriented stock. NVS, KO, PEP, PFE pay a dividend while ACNT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.